Concepedia

Carlos Álvarez-Ortega

CÁ

Statistics

Publications

4

Citations

412

H-Index

4

Active since

2020

Affiliations

Hospital Universitario Infanta Sofía(Current)

Bellvitge University Hospital

Universidad Autónoma de Madrid

Universidade de Santiago de Compostela

Hospital Universitario La Paz

Carlos Álvarez-Ortega is an author at Hospital Universitario Infanta Sofía specializing in medicine, oncology, and cancer therapy-related cardiotoxicity.

ORCID

Publications per year

2020–2024

4

Publications

4

Classification, prevalence, and outcomes of anticancer therapy-induced cardiotoxicity: the CARDIOTOX registry

José López‐Sendón, Carlos Álvarez-Ortega, Pilar Auñón et al. · European Heart Journal · 2020 · 284 citations · Full text

, , +17

Cardiovascular risk factors during cancer treatment. Prevalence and prognostic relevance: insights from the CARDIOTOX registry

Juan Caro‐Codón, Teresa López‐Fernández, Carlos Álvarez-Ortega et al. · European Journal of Preventive Cardiology · 2020 · 63 citations

, , +17

Anthracycline-induced cardiovascular toxicity: validation of the Heart Failure Association and International Cardio-Oncology Society risk score

Borja Rivero Santana, Jesús Saldaña García, Juan Caro‐Codón et al. · European Heart Journal · 2024 · 50 citations · Full text

, , +16

Predictors of Clinical Success of Cardioneuroablation in Patients With Syncope

María Teresa Barrio-López, Carlos Álvarez-Ortega, Carlos Minguito‐Carazo et al. · JACC. Clinical electrophysiology · 2024 · 15 citations

, , +6

1–4 of 4